<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2024.1384676</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Congenital anomalies of the kidney and urinary tract</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Mahmoud</surname> <given-names>Anfal Hussain</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2777594/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Talaat</surname> <given-names>Iman M.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/973829/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Tlili</surname> <given-names>Abdelaziz</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/568846/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Hamoudi</surname> <given-names>Rifat</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<xref ref-type="corresp" rid="c003"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/780927/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Research Institute for Medical and Health Sciences, College of Medicine, University of Sharjah</institution>, <addr-line>Sharjah</addr-line>, <country>United Arab Emirates</country></aff>
<aff id="aff2"><sup>2</sup><institution>Clinical Sciences Department, College of Medicine, University of Sharjah</institution>, <addr-line>Sharjah</addr-line>, <country>United Arab Emirates</country></aff>
<aff id="aff3"><sup>3</sup><institution>Pathology Department, Faculty of Medicine, Alexandria University</institution>, <addr-line>Alexandria</addr-line>, <country>Egypt</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Applied Biology, College of Sciences, University of Sharjah</institution>, <addr-line>Sharjah</addr-line>, <country>United Arab Emirates</country></aff>
<aff id="aff5"><sup>5</sup><institution>BIMAI-Lab, Biomedically Informed Artificial Intelligence Laboratory, University of Sharjah</institution>, <addr-line>Sharjah</addr-line>, <country>United Arab Emirates</country></aff>
<aff id="aff6"><sup>6</sup><institution>Division of Surgery and Interventional Science, University College London</institution>, <addr-line>London</addr-line>, <country>United Kingdom</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001">
<p>Edited by: Rajendra Bhimma, University of KwaZulu-Natal, South Africa</p>
</fn>
<fn fn-type="edited-by" id="fn0002">
<p>Reviewed by: Natalija Filipovic, University of Split, Croatia</p>
<p>Ana Cristina Sim&#x00F5;es E. Silva, Federal University of Minas Gerais, Brazil</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Iman M. Talaat, <email>italaat@sharjah.ac.ae</email></corresp>
<corresp id="c002">Abdelaziz Tlili, <email>atlili@sharjah.ac.ae</email></corresp>
<corresp id="c003">Rifat Hamoudi, <email>rhamoudi@sharjah.ac.ae</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>07</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>11</volume>
<elocation-id>1384676</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>02</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>06</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Mahmoud, Talaat, Tlili and Hamoudi.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Mahmoud, Talaat, Tlili and Hamoudi</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) refer to a range of conditions that affect the kidney and urinary tract. These anomalies can be severe, such as kidney agenesis, or milder, such as vesicoureteral reflux. CAKUT affects over 1% of live births and accounts for 40&#x2013;50% of cases of chronic kidney failure in children. The pathogenesis of CAKUT is caused by various environmental, genetic, and epigenetic factors that disrupt normal nephrogenesis. Environmental factors that can lead to CAKUT include maternal diabetes, obesity, malnutrition, alcohol consumption, or medications affecting kidneys development. Genetic factors can cause an imbalance in the metanephros and the ureteric bud interaction. Defects in specific genes such as PAX2, TBX18, NRIP1, REX, SIX2, BMP4, and chromosome 17 cause CAKUT. Over 50 genes have been identified as the root cause of this condition, with monogenetic variants causing up to 20% of all cases. CAKUTs can be diagnosed through fetal ultrasonography, but some anomalies may remain undetected. GWASs, Next Generation Sequencing for targeted and whole exome DNA sequencing may provide additional diagnostic methods. This review article highlights some the leading factors that cause CAKUT, which adversely affects kidney development and urinary tract function.</p>
</abstract>
<kwd-group>
<kwd>CAKUT</kwd>
<kwd>kidney anomalies</kwd>
<kwd>metanephros</kwd>
<kwd>ureteric bud</kwd>
<kwd>ultrasonography</kwd>
</kwd-group>
<contract-num rid="cn1">22010902103</contract-num>
<contract-num rid="cn2">20010902102</contract-num>
<contract-sponsor id="cn1">University of Sharjah</contract-sponsor>
<contract-sponsor id="cn2">University of Sharjah</contract-sponsor>
<counts>
<fig-count count="2"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="38"/>
<page-count count="8"/>
<word-count count="5018"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Nephrology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<title>Introduction</title>
<p>CAKUTs refer to congenital anomalies that affect the kidney and urinary tract structures, including kidneys, ureters, bladder, and urethra (<xref ref-type="bibr" rid="ref1">1</xref>). The urinary tract development may be disturbed at any point in embryogenesis, causing developmental abnormalities with diverse manifestations (<xref ref-type="bibr" rid="ref2">2</xref>).</p>
<p>CAKUT can be isolated (non-syndromic) or with other phenotypes that affect other organs (syndromic). Moreover, it can be observed as a bilateral malformation affecting both kidneys and a unilateral malformation that affects only one kidney. The anatomical classification of CAKUT is complex due to the variability in phenotype, including incomplete penetrance and variable expression (<xref ref-type="bibr" rid="ref2">2</xref>). However, the advent of new genomic technology, which can detect sequence variations, has enabled scientists to categorize defects according to their genetic architecture (<xref ref-type="bibr" rid="ref3">3</xref>).</p>
<p>Many genes are involved in embryonic kidney development, which is also mutant in CAKUT patients (<xref ref-type="bibr" rid="ref1">1</xref>). Furthermore, Van der Ven et al. identified 40 monogenic mutations leading to CAKUT and hypothesized that there is a high frequency of CAKUT phenotypes caused by single gene variations (<xref ref-type="bibr" rid="ref2">2</xref>).</p>
<p>These studies indicate the genetic heterogeneity impact on CAKUTs, ultimately discovering new fundamental pathways. Further studies are required to confirm the mutagenesis of several other genes associated with essential developmental pathways (<xref ref-type="bibr" rid="ref4">4</xref>). Moreover, recent studies have demonstrated that environmental and epigenetic factors influence CAKUT occurrence (<xref ref-type="bibr" rid="ref5">5</xref>). Hence, understanding the etiology underlining CAKUT will improve diagnostic strategies and discover advanced therapeutic approaches.</p>
<p>This review article aims to investigate the etiology of CAKUT by highlighting the genetic, epigenetic, and environmental factors that contribute to the development of the disease. Furthermore, exploring the development complexity of kidney and urinary tract and how this process perturbs.</p>
</sec>
<sec id="sec2">
<title>Epidemiology of CAKUT</title>
<p>CAKUT occurs in over 1% of live births, accounting for 23% of all birth defects (<xref ref-type="bibr" rid="ref6">6</xref>), and implicating in 34&#x2013;59 percent cases of chronic kidney disease. Additionally, CAKUT is a significant cause of kidneys failure since it occurs in 40&#x2013;50% of pediatric patients and 7% of adults who suffer from chronic kidney failure (<xref ref-type="bibr" rid="ref7">7</xref>, <xref ref-type="bibr" rid="ref8">8</xref>). CAKUT have been associated with an increased risk of urinary tract cancer in later life. Pathways affected by CAKUT have also been identified as potential contributors to the development of cancer (<xref ref-type="bibr" rid="ref9">9</xref>).</p>
</sec>
<sec id="sec3">
<title>Development of CAKUT</title>
<p>Development of the urinary tract begins during the third week of gestation with the emergence of the nephrogenic cord from the intermediate mesoderm found on both sides of the embryo. This nephrogenic cord will form three structures that emerge sequentially on the dorsal body wall: the pronephros, mesonephros, and metanephros (<xref ref-type="fig" rid="fig1">Figure 1</xref>) (<xref ref-type="bibr" rid="ref10">10</xref>).</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Timeline of kidney development in humans (<xref ref-type="bibr" rid="ref5">5</xref>, <xref ref-type="bibr" rid="ref10">10</xref>).</p>
</caption>
<graphic xlink:href="fmed-11-1384676-g001.tif"/>
</fig>
<p>Initially, pronephros will arise as a nonfunctional and immature kidney. Subsequently, this structure will regress, and the mesonephros will emerge to form a mesonephric duct that will elongate caudally to join the (cloaca), forming the urinary bladder. Additionally, a portion of the duct will protrude to form an epithelial tube known as a uretic bud (UB) surrounded by metanephric mesenchymal (MM). The UB will send a continuous reciprocal signal to the MM, initiating and enhancing the branching process of the UB and consequently forming an ultimate adult kidney by the end of week 32 of gestation (<xref ref-type="bibr" rid="ref5">5</xref>, <xref ref-type="bibr" rid="ref11">11</xref>). A molecular signal disturbance between these two compartments may cause CAKUT manifestations (<xref ref-type="bibr" rid="ref3">3</xref>). Severe cases of CAKUT can result in life-threatening conditions such as hydronephrosis, which leads to fibrosis and kidneys failure (<xref ref-type="bibr" rid="ref1">1</xref>).</p>
</sec>
<sec id="sec4">
<title>Pathogenesis of CAKUT</title>
<p>Besides the molecular disturbance during embryonic development, CAKUT can also result from environmental, epigenetic, or genetic factors (<xref ref-type="bibr" rid="ref12">12</xref>).</p>
<sec id="sec5">
<title>Environmental factors</title>
<p>Several maternal conditions can affect the <italic>in-utero</italic> environment and lead to the development of CAKUT (<xref ref-type="bibr" rid="ref12">12</xref>). These conditions include diabetes, chronic kidney disease, cancer, and obesity (<xref ref-type="bibr" rid="ref13 ref14 ref15">13&#x2013;15</xref>). Excessive intake of folic acid or deficiency in vitamin A during pregnancy is also associated with CAKUT manifestations (<xref ref-type="bibr" rid="ref1">1</xref>, <xref ref-type="bibr" rid="ref3">3</xref>). Furthermore, some medications, such as angiotensin-converting enzyme inhibitors (ACE), can impair kidneys development (<xref ref-type="bibr" rid="ref8">8</xref>, <xref ref-type="bibr" rid="ref16">16</xref>) Maternal malnutrition and a low-protein diet during pregnancy can have a detrimental impact on the developing kidneys system (<xref ref-type="bibr" rid="ref5">5</xref>).</p>
</sec>
<sec id="sec6">
<title>Epigenetic factors</title>
<p>CAKUT epigenetic factors include DNA methylation, histone modifications, and non-coding RNAs. These epigenetic mechanisms control gene expression via activating or silencing regulatory genes essential for kidney and urinary tract development (<xref ref-type="bibr" rid="ref3">3</xref>). Alterations to epigenetic marks that regulate developmental genes in the kidney and urinary tract can increase the risk of CAKUT phenotypes (<xref ref-type="bibr" rid="ref12">12</xref>).</p>
</sec>
<sec id="sec7">
<title>Genetic factors</title>
<p>Multiple genetic factors may contribute to CAKUT, including monogenic mutations, copy number, and structural variations, leading to an imbalance in some proteins and dysregulation of essential receptors and signaling pathways. Furthermore, Van der Ven et al. hypothesize that there is a high frequency of CAKUT phenotypes caused by monogenic variations in genes related to kidney development (<xref ref-type="bibr" rid="ref2">2</xref>). These monogenic mutations account for up to 20% of all CAKUT cases in human populations and include more than 50 genes causing CAKUT, such as PAX2, TBX18, NRIP1, REX, SIX2, and BMP4 (<xref ref-type="bibr" rid="ref4">4</xref>).</p>
</sec>
</sec>
<sec id="sec8">
<title>The current state of CAKUT genetic etiology</title>
<p>CAKUT occurs due to genetic factors, including defects in specific genes, rare genetic syndromes, and mutations in genes causing protein imbalance that affect kidney development or result in gene dysfunction. The gene variants linked to CAKUT include monogenic variants and copy number variations resulting in the down-regulation receptors, affecting various signaling pathways (<xref ref-type="bibr" rid="ref12">12</xref>).</p>
<sec id="sec9">
<title>Monogenetic variants</title>
<p>This section explores how variations in single genes increase the risk of CAKUT. Monogenic causes of CAKUT can be detected through various genetic screening techniques, such as single-gene screening, gene panels, and whole-exome sequencing. These techniques offer an in-depth analysis of specific genes or the entire exome, allowing for the identification of single-gene mutations responsible for CAKUT (<xref ref-type="bibr" rid="ref12">12</xref>). TBX18 and NRIP1 genes are the common monogenic causes of CAKUT. They increase ureteric mesenchymal cell development defects and retinoic acid signaling, contributing to disease pathogenesis (<xref ref-type="bibr" rid="ref4">4</xref>). PAX2 variants are a known cause of monogenic CAKUT. These mutations are associated with (syndromic CAKUT), which is associated with ocular anomalies. Monogenic variations are caused by a combination of familial genetic, epigenetic, and environmental factors. They account for up to 20% of all CAKUT cases in human populations and include around 68 monogenetic causes (39 dominant, 26 recessive, and 4 X-linked) (<xref ref-type="table" rid="tab1">Table 1</xref>). Mutations in monogenic variants increase the prevalence of CAKUT genes in humans because they create genetic imbalances, alter genetic composition, and modify or delete genes (<xref ref-type="bibr" rid="ref4">4</xref>).</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Genetic risks related to CAKUT, including autosomal dominant, recessive, and X-linked mutations.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="top">Gene</th>
<th align="left" valign="top">Protein</th>
<th align="center" valign="top">AD, AR, XL</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">1</td>
<td align="center" valign="top">ACE</td>
<td align="left" valign="top">Angiotensin I&#x2013;converting enzyme</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">2</td>
<td align="center" valign="top">AGT</td>
<td align="left" valign="top">Angiotensinogen</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">3</td>
<td align="center" valign="top">AGTR1</td>
<td align="left" valign="top">Angiotensin II receptor</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">4</td>
<td align="center" valign="top">AIFM3</td>
<td align="left" valign="top">Apoptosis-inducing factor, mitochondria associated 3</td>
<td align="center" valign="top">XL</td>
</tr>
<tr>
<td align="left" valign="top">5</td>
<td align="center" valign="top">BMP4</td>
<td align="left" valign="top">Bone morphogenic protein 4</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">6</td>
<td align="center" valign="top">BNC2</td>
<td align="left" valign="top">Zinc finger protein basonuclin-2</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">7</td>
<td align="center" valign="top">CBWD1</td>
<td align="left" valign="top">Cobalamin Synthetase W Domain&#x2013;Containing Protein 1</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">8</td>
<td align="center" valign="top">CHD1L</td>
<td align="left" valign="top">Chromodomain helicase DNA binding protein 1 like</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">9</td>
<td align="center" valign="top">CHRM3</td>
<td align="left" valign="top">Muscarinic acetylcholine receptor M3</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">10</td>
<td align="center" valign="top">CHRNA3</td>
<td align="left" valign="top">Cholinergic Receptor Nicotinic Alpha 3 Subunit</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">11</td>
<td align="center" valign="top">COL4A1</td>
<td align="left" valign="top">Collagen alpha 1(IV) chain</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">12</td>
<td align="center" valign="top">CRELD2</td>
<td align="left" valign="top">Cysteine Rich With EGF Like Domains 2</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">13</td>
<td align="center" valign="top">CRKL</td>
<td align="left" valign="top">CRK-like proto-oncogene, an adaptor protein</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">14</td>
<td align="center" valign="top">DAB1</td>
<td align="left" valign="top">DAB adaptor protein 1</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">15</td>
<td align="center" valign="top">DSTYK</td>
<td align="left" valign="top">Dual serine/threonine and tyrosine protein kinase</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">16</td>
<td align="center" valign="top">EYA1</td>
<td align="left" valign="top">Eyes absent homolog 1</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">17</td>
<td align="center" valign="top">FGF20</td>
<td align="left" valign="top">Fibroblast growth factor 20</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">18</td>
<td align="center" valign="top">FOXA2</td>
<td align="left" valign="top">Forkhead box A2</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">19</td>
<td align="center" valign="top">FOXA3</td>
<td align="left" valign="top">Forkhead box A3: Hepatocyte nuclear factor 3-gamma: HNF3G</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">20</td>
<td align="center" valign="top">FOXC1</td>
<td align="left" valign="top">Forkhead box protein C1</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">21</td>
<td align="center" valign="top">FOXL2</td>
<td align="left" valign="top">Forkhead transcription factor</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">22</td>
<td align="center" valign="top">FOXP1</td>
<td align="left" valign="top">Forkhead box protein P1</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">23</td>
<td align="center" valign="top">FRAS1</td>
<td align="left" valign="top">ECM protein FRAS1</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">24</td>
<td align="center" valign="top">FREM1</td>
<td align="left" valign="top">FRAS1-related ECM protein</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">25</td>
<td align="center" valign="top">FREM2</td>
<td align="left" valign="top">FRAS1-related ECM protein</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">26</td>
<td align="center" valign="top">GATA3</td>
<td align="left" valign="top">GATA binding protein 3</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">27</td>
<td align="center" valign="top">GEN1</td>
<td align="left" valign="top">Holiday junction 5-prime flap endonuclease</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">29</td>
<td align="center" valign="top">GFRA1</td>
<td align="left" valign="top">GDNF family receptor alpha 1</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">30</td>
<td align="center" valign="top">GDF6</td>
<td align="left" valign="top">Growth/ Differentiation factor 6</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">31</td>
<td align="center" valign="top">GREB1L</td>
<td align="left" valign="top">GREB1-like protein</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">32</td>
<td align="center" valign="top">GRIP1</td>
<td align="left" valign="top">Glutamate receptor-interacting protein</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">33</td>
<td align="center" valign="top">HNF1B</td>
<td align="left" valign="top">HNF homeobox B</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">34</td>
<td align="center" valign="top">HOXA11</td>
<td align="left" valign="top">Homeobox protein Hox-A11</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">35</td>
<td align="center" valign="top">HPSE2</td>
<td align="left" valign="top">Heparanase 2 (inactive)</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">36</td>
<td align="center" valign="top">ITGA10</td>
<td align="left" valign="top">Integrin Alpha-10</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">37</td>
<td align="center" valign="top">ITGA8</td>
<td align="left" valign="top">Integrin Alpha-8</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">38</td>
<td align="center" valign="top">KAL1/ANOS1</td>
<td align="left" valign="top">Anosmin 1</td>
<td align="center" valign="top">XL</td>
</tr>
<tr>
<td align="left" valign="top">39</td>
<td align="center" valign="top">KIF4A</td>
<td align="left" valign="top">Kinesin family member 4 A</td>
<td align="center" valign="top">XLR</td>
</tr>
<tr>
<td align="left" valign="top">40</td>
<td align="center" valign="top">LRIG2</td>
<td align="left" valign="top">Leucine-rich repeats and Ig-like domains 2</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">41</td>
<td align="center" valign="top">MUC1</td>
<td align="left" valign="top">Mucin 1</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">42</td>
<td align="center" valign="top">NRIP1</td>
<td align="left" valign="top">Nuclear receptor-interacting protein 1</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">43</td>
<td align="center" valign="top">PAX2</td>
<td align="left" valign="top">Paired box 2</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">44</td>
<td align="center" valign="top">PBX1</td>
<td align="left" valign="top">PBX homeobox 1</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">45</td>
<td align="center" valign="top">PLS3</td>
<td align="left" valign="top">PALSTIN 3: maintenance of normal kidney function</td>
<td align="center" valign="top">XLD</td>
</tr>
<tr>
<td align="left" valign="top">46</td>
<td align="center" valign="top">REN</td>
<td align="left" valign="top">Renin</td>
<td align="center" valign="top">AR, AD</td>
</tr>
<tr>
<td align="left" valign="top">48</td>
<td align="center" valign="top">RET</td>
<td align="left" valign="top">Proto-oncogene tyrosine-protein kinase receptor Ret</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">49</td>
<td align="center" valign="top">ROBO2</td>
<td align="left" valign="top">Roundabout, axon guidance receptor, homolog 2 (Drosophila)</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">50</td>
<td align="center" valign="top">SALL1</td>
<td align="left" valign="top">Sal-like protein 1 (also known as spalt-like transcription factor 1)</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">51</td>
<td align="center" valign="top">SIX2</td>
<td align="left" valign="top">SIX homeobox 2</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">52</td>
<td align="center" valign="top">SIX5</td>
<td align="left" valign="top">SIX homeobox 5</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">53</td>
<td align="center" valign="top">SLC20A1</td>
<td align="left" valign="top">Solute carrier family 20 (phosphate transporter) member 1</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">54</td>
<td align="center" valign="top">SLIT2</td>
<td align="left" valign="top">Slit homolog 2</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">55</td>
<td align="center" valign="top">SON</td>
<td align="left" valign="top">Protein SON</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">56</td>
<td align="center" valign="top">SOX17</td>
<td align="left" valign="top">Transcription factor SIX-17</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">57</td>
<td align="center" valign="top">SRGAP1</td>
<td align="left" valign="top">SLIT-ROBO Rho GTPase activating protein 1</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">58</td>
<td align="center" valign="top">TBC1D1</td>
<td align="left" valign="top">TBC1 domain family member 1</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">59</td>
<td align="center" valign="top">TBX18</td>
<td align="left" valign="top">T-box transcription factor TBX18</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">60</td>
<td align="center" valign="top">TBX6</td>
<td align="left" valign="top">T-box transcription factor TBX6</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">61</td>
<td align="center" valign="top">TNXB</td>
<td align="left" valign="top">Tenascin XB</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">62</td>
<td align="center" valign="top">TRAP1</td>
<td align="left" valign="top">Heat shock protein 75 (TNF receptor&#x2013;associated protein 1)</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">63</td>
<td align="center" valign="top">UMOD</td>
<td align="left" valign="top">Uromodulin</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">64</td>
<td align="center" valign="top">UPK3A</td>
<td align="left" valign="top">Uroplakin</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">65</td>
<td align="center" valign="top">VWA2</td>
<td align="left" valign="top">Von Willebrand factor A domain-containing protein 2</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">66</td>
<td align="center" valign="top">WNT4</td>
<td align="left" valign="top">Protein Wnt-4</td>
<td align="center" valign="top">AD</td>
</tr>
<tr>
<td align="left" valign="top">67</td>
<td align="center" valign="top">WNT9B</td>
<td align="left" valign="top">Wingless&#x2014;type MMTV integration site family, member 9B</td>
<td align="center" valign="top">AR</td>
</tr>
<tr>
<td align="left" valign="top">68</td>
<td align="center" valign="top">ZMYM2</td>
<td align="left" valign="top">Zinc finger MYM-type protein 2</td>
<td align="center" valign="top">AD</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>AD, autosomal dominate; AR, autosomal recessive; XL, linked to chromosome X; XLR, a recessive mutation linked to X chromosome; XLD, a dominate mutation linked to X chromosome.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec10">
<title>Copy number variations</title>
<p>Copy number variants (CNVs) are a significant genetic risk factor for CAKUT. CNVs can result in kidney and urinary tract defects by altering the expression of genes that are vital for proper kidney formation (<xref ref-type="bibr" rid="ref3">3</xref>). Specifically, CNVs can lead to deletions or duplications of chromosomal regions that harbor genes necessary for kidney development. These alterations can cause an imbalance in gene expression, ultimately resulting in CAKUT phenotypes (<xref ref-type="bibr" rid="ref1">1</xref>). Specific CNVs that have been associated with CAKUT include HNFB1/Hepatocyte nuclear factor 1-&#x03B2; (on Chromosome 17) and PAX genes (<xref ref-type="bibr" rid="ref2">2</xref>). Although CNVs only account for about 5% of CAKUT cases, they provide evidence that other genetic variations can also lead to CAKUT disorders (<xref ref-type="bibr" rid="ref1">1</xref>).</p>
<p>In CAKUT, severe phenotypes observed in offspring of healthy parents can be attributed to <italic>de novo</italic> dominant mutations in essential developmental genes or recessive mutations in genes that can tolerate reduced gene dosage. In contrast, familial cases of CAKUT, which represent 10&#x2013;20% of cases, often exhibit incomplete penetrance as an autosomal dominant trait. This incomplete penetrance may arise from genetic or environmental modifiers that influence disease manifestation, hypomorphic mutations that partially impair kidney development, or disruption of genes and pathways essential for urinary tract development later in life (<xref ref-type="bibr" rid="ref4">4</xref>). Structural disorders such as vesicoureteral reflux (VUR) and duplex collecting systems (DCS) are more prevalent because they have a lesser impact on overall survival. This is because they can either remain asymptomatic or spontaneously resolve over time. These common disorders may have a polygenic basis, meaning that they are caused by the combined effects of multiple common genetic variants. These variants have modest effects on an individual&#x2019;s risk of developing the disorder, and they are less likely to be influenced by selective pressures (<xref ref-type="bibr" rid="ref4">4</xref>).</p>
</sec>
</sec>
<sec id="sec11">
<title>The phenotypic spectrum of CAKUT</title>
<p>Embryonic development of the urinary tract system is a complex process. CAKUT phenotypes may arise from disrupting this process (<xref ref-type="bibr" rid="ref4">4</xref>). In particular, a disturbance in the communication between the metanephric mesenchyme (MM) and the ureteric bud (UB) that arises from the nephric duct can result in CAKUT (<xref ref-type="bibr" rid="ref8">8</xref>). The location of ureteric bud (UB) emergence along the nephric duct is a crucial determinant of CAKUT phenotype. In the case of a low insertion of the UB, (vesicoureteral reflux) will result, while a high insertion results in (obstructive uropathy) (<xref ref-type="bibr" rid="ref3">3</xref>). CAKUT phenotypes are highly variable between individuals, and multiple anomalies can co-occur within a single patient. CAKUT can occur alone (non-syndromic CAKUT) or in association with other syndromes and diseases (syndromic CAKUT). The severity of CAKUT varies widely, and the condition can cause a variety of structural abnormalities in the kidneys, ureters, and lower urinary tract (<xref ref-type="bibr" rid="ref3">3</xref>).</p>
<sec id="sec12">
<title>Anomalies of the kidneys</title>
<p>An early embryonic maldevelopment can result in several kidney parenchymal defects, including:</p><list list-type="order">
<list-item>
<p>
<bold>Kidney agenesis</bold>
</p>
</list-item>
</list>
<p>Kidney agenesis refers to a congenital anomaly characterized by the absence of one or both kidneys (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). It can be isolated or part of multi-organ syndromes (<xref ref-type="bibr" rid="ref5">5</xref>). The exact mechanisms underlying it are not fully understood, but genetic and environmental factors are likely causes. It can be detected early in pregnancy using ultrasonography. The occurrence of kidney agenesis has been linked to pathogenic variants in three specific genes: ITGA8, GREB1L, and FGF20 (<xref ref-type="bibr" rid="ref17">17</xref>).</p><list list-type="order">
<list-item>
<p>
<bold>Hypoplasia</bold>
</p>
</list-item>
</list>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Anomalies of the kidneys are illustrated in <bold>(A&#x2013;E)</bold>, anomalies of the ureter are shown in <bold>(F&#x2013;I)</bold>, and anomalies of the lower urinary tract are depicted in <bold>(J&#x2013;L)</bold>. CAKUT phenotypic spectrum includes kidney anomalies, ureter, and lower Urinary tract. <bold>(A)</bold> Renal agenesis, <bold>(B)</bold> Hypoplasia, <bold>(C)</bold> Dysplasia, <bold>(D)</bold> Ectopic kidney, <bold>(E)</bold> Horseshoe kidney, <bold>(F)</bold> UPJO; ureteropelvic junction obstruction, <bold>(G)</bold> Primary megaureter, <bold>(H)</bold> Duplex collecting system, <bold>(I)</bold> VUR; vesicoureteral reflux, <bold>(J)</bold> Bladder exstrophy, <bold>(K)</bold> Bladder agenesis, <bold>(L)</bold> Posterior urethral valves.</p>
</caption>
<graphic xlink:href="fmed-11-1384676-g002.tif"/>
</fig>
<p>Kidney hypoplasia is a congenital kidney malformation characterized by an abnormally small kidney with a decreased number of nephrons (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Kidney hypoplasia has a significant impact on kidneys function, potentially leading to oligohydramnios syndrome during pregnancy and, ultimately, chronic kidney failure in severe cases (<xref ref-type="bibr" rid="ref5">5</xref>, <xref ref-type="bibr" rid="ref18">18</xref>). This disease can be inherited through dominant and recessive inheritance modes (<xref ref-type="bibr" rid="ref19">19</xref>). Multiple signaling pathways contribute to kidney hypoplasia. These pathways include the Fibroblast Growth Factor (FGF), Hedgehog (HH), Glial Cell Line-Derived Neurotrophic Factor/Ret (GDNF/Ret), and Paired Box 2 (PAX2) pathways (<xref ref-type="bibr" rid="ref18">18</xref>).</p><list list-type="order">
<list-item>
<p>
<bold>Dysplasia</bold>
</p>
</list-item>
</list>
<p>Kidney dysplasia is a kidney malformation that can occur as a result of various dysplastic conditions (<xref ref-type="fig" rid="fig2">Figure 2C</xref>), including multicystic dysplastic kidney (MCDK), cystic dysplasia, and obstructive kidney dysplasia (ORD) (<xref ref-type="bibr" rid="ref18">18</xref>, <xref ref-type="bibr" rid="ref20">20</xref>). It can be inherited as an autosomal dominant and is associated with mutations in ITGA8 and FGF20 genes essential for kidney growth and development (<xref ref-type="bibr" rid="ref21">21</xref>). Furthermore, PAX2 gene mutation or its interaction with p53 pathway can cause kidney dysplasia, leading to impaired nephron induction and abnormal ureteric bud budding from mesonephric duct (<xref ref-type="bibr" rid="ref20">20</xref>).</p>
<p>Other types of kidney anomalies include ectopic pelvic kidneys, which occur when the kidney fails to ascend to its final position (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Therefore, the kidney will remain in the pelvis, affecting the normal position and function of the kidney (<xref ref-type="bibr" rid="ref22">22</xref>). A horseshoe kidney occurs when both sides of the vertebral column contain functional kidneys masses fused with uncrossed ureters extending from the kidneys hilum to the urinary bladder (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). This malformation affects the kidney&#x2019;s shape, rotation, position, and vascular supply (<xref ref-type="bibr" rid="ref23">23</xref>).</p>
</sec>
<sec id="sec13">
<title>Anomalies of ureter</title>
<p>Later embryonic maldevelopment causes several ureteral defects, including:</p><list list-type="order">
<list-item>
<p>
<bold>Ureteropelvic junction obstruction (UPJO)</bold>
</p>
</list-item>
</list>
<p>Ureteropelvic junction obstruction is a functional obstruction that causes partial or intermittent complete blockage of urine flow from the kidney, leading to hydronephrosis (<xref ref-type="fig" rid="fig2">Figure 2F</xref>) (<xref ref-type="bibr" rid="ref24">24</xref>). This condition can trigger urinary tract infections or urine retention, resulting in acute kidney injury and even kidneys failure (<xref ref-type="bibr" rid="ref8">8</xref>). CUPO is a congenital disorder caused by various genes with autosomal dominant inheritance. However, it can also be caused by acquired etiologies resulting in obstruction (<xref ref-type="bibr" rid="ref25">25</xref>).</p><list list-type="order">
<list-item>
<p>
<bold>Primary nonobstructive non refluxing megaureter kidney</bold>
</p>
</list-item>
</list>
<p>Primary non-obstructive non-refluxing megaureters, which occur in males and constitute 5 to 10% of all cases of prenatal hydronephrosis, are caused by congenital dilation of the ureter (<xref ref-type="fig" rid="fig2">Figure 2G</xref>) (<xref ref-type="bibr" rid="ref26">26</xref>, <xref ref-type="bibr" rid="ref27">27</xref>). Several causes of megaureters include obstruction, reflex, or neither. As part of the diagnostic process, ultrasounds, cystourethrograms, and isotopic renograms apply to patients with this disease (<xref ref-type="bibr" rid="ref27">27</xref>).</p><list list-type="order">
<list-item>
<p>
<bold>Duplex collecting system</bold>
</p>
</list-item>
</list>
<p>Duplex kidneys are a rare condition where the kidney pelvis and ureter are duplicated, resulting in a double uretic tip (<xref ref-type="fig" rid="fig2">Figure 2H</xref>) (<xref ref-type="bibr" rid="ref5">5</xref>). This condition is estimated to occur more in females than males. The development of duplex kidneys is caused by a defect in the interactions between the metanephric mesenchymal and the nephric duct, which initiates the ureter. The GDNF/RET signaling axis is a crucial pathway that triggers the RET signaling cascade for the growth of the urinary bladder. The involvement of modifier genes in these cascades could lead to duplex kidney development if disrupted. This condition can lead to several kidneys disorders, including hydronephrosis, pelvic-calyceal dilatation, and cortical scarring (<xref ref-type="bibr" rid="ref28">28</xref>).</p><list list-type="order">
<list-item>
<p>
<bold>Vesicoureteral reflux (VUR)</bold>
</p>
</list-item>
</list>
<p>Vesicoureteral reflux (VUR) is a congenital condition where urine flows back from the bladder into the ureters, leading to complications like kidney damage, urinary tract infections, and high blood pressure (<xref ref-type="fig" rid="fig2">Figure 2I</xref>) (<xref ref-type="bibr" rid="ref29">29</xref>). It occurs in 1&#x2013;2% of the population and can be primary or secondary (<xref ref-type="bibr" rid="ref30">30</xref>). VUR is caused by ectopic embryonal ureteric budding and is linked to genes like EYA1, ROBO2, RET/GDNF, and PAX2 (<xref ref-type="bibr" rid="ref31">31</xref>).</p>
</sec>
<sec id="sec14">
<title>Anomalies of the lower urinary tract</title>
<p>As embryonic development continues, a variety of malformations can occur in the lower urinary tract, including:</p><list list-type="order">
<list-item>
<p>
<bold>Bladder exstrophy</bold>
</p>
</list-item>
</list>
<p>Bladder exstrophy is a rare congenital malformation that occurs when the bladder develops outside the fetus, causing it to function abnormally (<xref ref-type="fig" rid="fig2">Figure 2J</xref>) (<xref ref-type="bibr" rid="ref32">32</xref>). This condition is caused by a defect in the formation of the cloacal membrane, which eventually ruptures and results in bladder exstrophy (<xref ref-type="bibr" rid="ref1">1</xref>, <xref ref-type="bibr" rid="ref32">32</xref>). Maternal factors like irradiation and smoking in the first trimester can cause severe cases of this malformation. However, folic acid consumption can help reduce the severity of the condition (<xref ref-type="bibr" rid="ref32">32</xref>).</p><list list-type="order">
<list-item>
<p>
<bold>Bladder agenesis</bold>
</p>
</list-item>
</list>
<p>Bladder agenesis is a rare condition that results from the failure of the mesonephric duct and ureter to interact during embryogenesis (<xref ref-type="fig" rid="fig2">Figure 2K</xref>). It leads to the absence of urine distention and ureteric ectopia, causing complications like kidney dysplasia and agenesis (<xref ref-type="bibr" rid="ref33">33</xref>, <xref ref-type="bibr" rid="ref34">34</xref>). Most cases occur in females, who may maintain kidneys function if their ureters drain into the genital tract. However, male neonates cannot survive unless ureters drain into the rectum or urachus. The prognosis and treatment options for this condition are often poor (<xref ref-type="bibr" rid="ref34">34</xref>).</p><list list-type="order">
<list-item>
<p>
<bold>Posterior urethral valves</bold>
</p>
</list-item>
</list>
<p>Posterior urethral valves are abnormal membranes that obstruct urine flow and cause ureter dilation and hydronephrosis (<xref ref-type="fig" rid="fig2">Figure 2L</xref>) (<xref ref-type="bibr" rid="ref8">8</xref>, <xref ref-type="bibr" rid="ref35">35</xref>). This condition affects 1 in 5,000 live male births, and 50% of cases progress to chronic kidney failure within 10 years. It can be detected prenatally or after birth, and the severity of the obstruction affects the prognosis (<xref ref-type="bibr" rid="ref36">36</xref>). Defects in the urinary tract&#x2019;s development can cause various abnormalities, including duplex kidneys, ectopic tissues, ureteral orifices, and horseshoe kidney (<xref ref-type="bibr" rid="ref5">5</xref>).</p><list list-type="order">
<list-item>
<p>
<bold>Current diagnostic approaches</bold>
</p>
</list-item>
</list>
<p>The kidneys system plays a crucial role as an excretory pathway in the human body, and any congenital anomalies in this system can significantly affect an infant&#x2019;s health. Such anomalies are responsible for approximately 40% of cases of chronic kidney failure in patients who develop the condition within the first three decades of their life. Chronic kidney failure can severely impact the quality of life as it progresses, making early detection and management of such anomalies an essential aspect of patient care (<xref ref-type="bibr" rid="ref2">2</xref>, <xref ref-type="bibr" rid="ref3">3</xref>, <xref ref-type="bibr" rid="ref37">37</xref>).</p>
<p>CAKUT encompasses a broad spectrum of kidneys disorders that affect individuals in various ways. While some anomalies can be diagnosed during fetal life through ultrasonography, others may not present until adulthood (<xref ref-type="bibr" rid="ref3">3</xref>). Genome-wide association studies (GWASs), next-generation DNA sequencing (NGS), and whole exome sequencing (WES) are additional techniques used to diagnose non-syndromic CAKUT. These methods are vital in identifying the underlying genetic causes of the disease (<xref ref-type="bibr" rid="ref3">3</xref>, <xref ref-type="bibr" rid="ref38">38</xref>).</p>
</sec>
</sec>
<sec sec-type="conclusions" id="sec15">
<title>Conclusion</title>
<p>Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) pose a significant challenge in the healthcare industry, particularly among infants and young children. CAKUT&#x2019;s complexity arises from multiple environmental, genetic, and epigenetic factors that interfere with normal nephrogenesis. A better understanding of CAKUT&#x2019;s molecular etiology and genetic causes is essential for identifying the progression causes, improving future prognosis, and providing genetic counseling to patients with CAKUT and their families, which will aid in gene therapy and personalized medicine.</p>
</sec>
<sec sec-type="author-contributions" id="sec16">
<title>Author contributions</title>
<p>AM: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. IT: Data curation, Writing &#x2013; review &#x0026; editing. AT: Writing &#x2013; original draft, Conceptualization, Data curation, Investigation, Writing &#x2013; review &#x0026; editing. RH: Writing &#x2013; review &#x0026; editing, Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Supervision, Writing &#x2013; original draft.</p>
</sec>
</body>
<back>
<sec sec-type="funding-information" id="sec17">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. RH is supported by University of Sharjah grant (code number: 22010902103). IT and RH are supported by University of Sharjah grant (code number: 20010902102).</p>
</sec>
<sec sec-type="COI-statement" id="sec18">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="disclaimer" id="sec19">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murugapoopathy</surname> <given-names>V</given-names></name> <name><surname>Gupta</surname> <given-names>IR</given-names></name></person-group>. <article-title>A primer on congenital anomalies of the kidneys and urinary tracts (CAKUT)</article-title>. <source>Clin J Am Soc Nephrol</source>. (<year>2020</year>) <volume>15</volume>:<fpage>723</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.2215/CJN.12581019</pub-id>, PMID: <pub-id pub-id-type="pmid">32188635</pub-id></citation>
</ref>
<ref id="ref2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>van der Ven</surname> <given-names>AT</given-names></name> <name><surname>Vivante</surname> <given-names>A</given-names></name> <name><surname>Hildebrandt</surname> <given-names>F</given-names></name></person-group>. <article-title>Novel insights into the pathogenesis of monogenic congenital anomalies of the kidney and urinary tract</article-title>. <source>J Am Soc Nephrol</source>. (<year>2018</year>) <volume>29</volume>:<fpage>36</fpage>&#x2013;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1681/ASN.2017050561</pub-id>, PMID: <pub-id pub-id-type="pmid">29079659</pub-id></citation>
</ref>
<ref id="ref3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Westland</surname> <given-names>R</given-names></name> <name><surname>Renkema</surname> <given-names>KY</given-names></name> <name><surname>Knoers</surname> <given-names>NVAM</given-names></name></person-group>. <article-title>Clinical integration of genome diagnostics for congenital anomalies of the kidney and urinary tract</article-title>. <source>Clin J Am Soc Nephrol</source>. (<year>2021</year>) <volume>16</volume>:<fpage>128</fpage>&#x2013;<lpage>37</lpage>. doi: <pub-id pub-id-type="doi">10.2215/CJN.14661119</pub-id>, PMID: <pub-id pub-id-type="pmid">32312792</pub-id></citation>
</ref>
<ref id="ref4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanna-Cherchi</surname> <given-names>S</given-names></name> <name><surname>Westland</surname> <given-names>R</given-names></name> <name><surname>Ghiggeri</surname> <given-names>GM</given-names></name> <name><surname>Gharavi</surname> <given-names>AG</given-names></name></person-group>. <article-title>Genetic basis of human congenital anomalies of the kidney and urinary tract</article-title>. <source>J Clin Invest</source>. (<year>2018</year>) <volume>128</volume>:<fpage>4</fpage>&#x2013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.1172/JCI95300</pub-id>, PMID: <pub-id pub-id-type="pmid">29293093</pub-id></citation>
</ref>
<ref id="ref5">
<label>5.</label>
<citation citation-type="other"><person-group person-group-type="author">
<name><surname>Winyard</surname> <given-names>PJD</given-names></name>
</person-group>. <article-title>Development of the kidneys and urinary tract in relation to renal anomalies</article-title> In: <source>Fetal Medicine: Basic Science and Clinical Practice</source> (<year>2019</year>). <fpage>114</fpage>&#x2013;<lpage>120.e2</lpage>.</citation>
</ref>
<ref id="ref6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kagan</surname> <given-names>M</given-names></name> <name><surname>Pleniceanu</surname> <given-names>O</given-names></name> <name><surname>Vivante</surname> <given-names>A</given-names></name></person-group>. <article-title>The genetic basis of congenital anomalies of the kidney and urinary tract</article-title>. <source>Pediatr Nephrol</source>. (<year>2022</year>) <volume>37</volume>:<fpage>2231</fpage>&#x2013;<lpage>43</lpage>. doi: <pub-id pub-id-type="doi">10.1007/S00467-021-05420-1</pub-id>, PMID: <pub-id pub-id-type="pmid">35122119</pub-id></citation>
</ref>
<ref id="ref7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Talati</surname> <given-names>AN</given-names></name> <name><surname>Webster</surname> <given-names>CM</given-names></name> <name><surname>Vora</surname> <given-names>NL</given-names></name></person-group>. <article-title>Prenatal genetic considerations of congenital anomalies of the kidney and urinary tract (CAKUT)</article-title>. <source>Prenat Diagn</source>. (<year>2019</year>) <volume>39</volume>:<fpage>679</fpage>&#x2013;<lpage>92</lpage>. doi: <pub-id pub-id-type="doi">10.1002/PD.5536</pub-id>, PMID: <pub-id pub-id-type="pmid">31343747</pub-id></citation>
</ref>
<ref id="ref8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Capone</surname> <given-names>VP</given-names></name> <name><surname>Morello</surname> <given-names>W</given-names></name> <name><surname>Taroni</surname> <given-names>F</given-names></name> <name><surname>Montini</surname> <given-names>G</given-names></name></person-group>. <article-title>Genetics of congenital anomalies of the kidney and urinary tract: the current state of play</article-title>. <source>Int J Mol Sci</source>. (<year>2017</year>) <volume>18</volume>:<fpage>796</fpage>. doi: <pub-id pub-id-type="doi">10.3390/IJMS18040796</pub-id>, PMID: <pub-id pub-id-type="pmid">28398236</pub-id></citation>
</ref>
<ref id="ref9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calderon-Margalit</surname> <given-names>R</given-names></name> <name><surname>Efron</surname> <given-names>G</given-names></name> <name><surname>Pleniceanu</surname> <given-names>O</given-names></name> <name><surname>Tzur</surname> <given-names>D</given-names></name> <name><surname>Stern-Zimmer</surname> <given-names>M</given-names></name> <name><surname>Afek</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Congenital anomalies of the kidney and urinary tract and adulthood risk of urinary tract Cancer</article-title>. <source>Kidney Int Rep</source>. (<year>2021</year>) <volume>6</volume>:<fpage>946</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.1016/J.EKIR.2021.01.003</pub-id>, PMID: <pub-id pub-id-type="pmid">33912744</pub-id></citation>
</ref>
<ref id="ref10">
<label>10.</label>
<citation citation-type="other"><person-group person-group-type="author"><name><surname>Devlieger</surname> <given-names>R</given-names></name> <name><surname>Hindryckx</surname> <given-names>A</given-names></name></person-group>. <article-title>Kidney and urinary tract disorders</article-title> In: <source>Fetal Medicine: Basic Science and Clinical Practice</source> (<year>2019</year>). <fpage>351</fpage>&#x2013;<lpage>372.e2</lpage>.</citation>
</ref>
<ref id="ref11">
<label>11.</label>
<citation citation-type="other"><person-group person-group-type="author"><name><surname>Hall</surname> <given-names>JE</given-names></name> <name><surname>Hall</surname> <given-names>ME</given-names></name></person-group>. <article-title>Guyton and hall textbook of medical physiology E-book</article-title>. (<year>2020</year>). <comment>Available at:</comment> <ext-link xlink:href="https://books.google.co.id/books?id=H1rrDwAAQBAJ" ext-link-type="uri">https://books.google.co.id/books?id=H1rrDwAAQBAJ</ext-link> (Accessed September 14, 2022).</citation>
</ref>
<ref id="ref12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nicolaou</surname> <given-names>N</given-names></name> <name><surname>Renkema</surname> <given-names>KY</given-names></name> <name><surname>Bongers</surname> <given-names>EMHF</given-names></name> <name><surname>Giles</surname> <given-names>RH</given-names></name> <name><surname>Knoers</surname> <given-names>NVAM</given-names></name></person-group>. <article-title>Genetic, environmental, and epigenetic factors involved in CAKUT</article-title>. <source>Nat Rev Nephrol</source>. (<year>2015</year>) <volume>11</volume>:<fpage>720</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrneph.2015.140</pub-id></citation>
</ref>
<ref id="ref13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dart</surname> <given-names>AB</given-names></name> <name><surname>Ruth</surname> <given-names>CA</given-names></name> <name><surname>Sellers</surname> <given-names>EA</given-names></name> <name><surname>Au</surname> <given-names>W</given-names></name> <name><surname>Dean</surname> <given-names>HJ</given-names></name></person-group>. <article-title>Maternal diabetes mellitus and congenital anomalies of the kidney and urinary tract (CAKUT) in the child</article-title>. <source>Am J Kidney Dis</source>. (<year>2015</year>) <volume>65</volume>:<fpage>684</fpage>&#x2013;<lpage>91</lpage>. doi: <pub-id pub-id-type="doi">10.1053/J.AJKD.2014.11.017</pub-id>, PMID: <pub-id pub-id-type="pmid">25595566</pub-id></citation>
</ref>
<ref id="ref14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Macumber</surname> <given-names>I</given-names></name> <name><surname>Schwartz</surname> <given-names>S</given-names></name> <name><surname>Leca</surname> <given-names>N</given-names></name></person-group>. <article-title>Maternal obesity is associated with congenital anomalies of the kidney and urinary tract in offspring</article-title>. <source>Pediatr Nephrol</source>. (<year>2017</year>) <volume>32</volume>:<fpage>635</fpage>&#x2013;<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00467-016-3543-x</pub-id>, PMID: <pub-id pub-id-type="pmid">27858197</pub-id></citation>
</ref>
<ref id="ref15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nishiyama</surname> <given-names>K</given-names></name> <name><surname>Sanefuji</surname> <given-names>M</given-names></name> <name><surname>Kurokawa</surname> <given-names>M</given-names></name> <name><surname>Iwaya</surname> <given-names>Y</given-names></name> <name><surname>Hamada</surname> <given-names>N</given-names></name> <name><surname>Sonoda</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>Maternal chronic disease and congenital anomalies of the kidney and urinary tract in offspring: a Japanese cohort study</article-title>. <source>Am J Kidney Dis</source>. (<year>2022</year>) <volume>80</volume>:<fpage>619</fpage>&#x2013;<lpage>628.e1</lpage>. doi: <pub-id pub-id-type="doi">10.1053/J.AJKD.2022.03.003</pub-id>, PMID: <pub-id pub-id-type="pmid">35439592</pub-id></citation>
</ref>
<ref id="ref16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname> <given-names>WO</given-names></name> <name><surname>Hernandez-Diaz</surname> <given-names>S</given-names></name> <name><surname>Arbogast</surname> <given-names>PG</given-names></name> <name><surname>Dudley</surname> <given-names>JA</given-names></name> <name><surname>Dyer</surname> <given-names>S</given-names></name> <name><surname>Gideon</surname> <given-names>PS</given-names></name> <etal/></person-group>. <article-title>Major congenital malformations after first-trimester exposure to ACE inhibitors</article-title>. <source>N Engl J Med</source>. (<year>2006</year>) <volume>354</volume>:<fpage>2443</fpage>&#x2013;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMOA055202</pub-id>, PMID: <pub-id pub-id-type="pmid">16760444</pub-id></citation>
</ref>
<ref id="ref17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalantari</surname> <given-names>S</given-names></name> <name><surname>Filges</surname> <given-names>I</given-names></name></person-group>. <article-title>Gene ontology enrichment analysis of renal agenesis: improving prenatal molecular diagnosis</article-title>. <source>Mol Syndromol</source>. (<year>2021</year>) <volume>12</volume>:<fpage>362</fpage>&#x2013;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000518115</pub-id>, PMID: <pub-id pub-id-type="pmid">34899145</pub-id></citation>
</ref>
<ref id="ref18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cain</surname> <given-names>JE</given-names></name> <name><surname>di Giovanni</surname> <given-names>V</given-names></name> <name><surname>Smeeton</surname> <given-names>J</given-names></name> <name><surname>Rosenblum</surname> <given-names>ND</given-names></name></person-group>. <article-title>Genetics of renal hypoplasia: insights into the mechanisms controlling nephron endowment</article-title>. <source>Pediatr Res</source>. (<year>2010</year>) <volume>68</volume>:<fpage>91</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1203/pdr.0b013e3181e35a88</pub-id></citation>
</ref>
<ref id="ref19">
<label>19.</label>
<citation citation-type="other"><person-group person-group-type="author">
<name><surname>Schott</surname> <given-names>HC</given-names></name>
</person-group>. <article-title>Chronic kidney disease</article-title> In: <source>Robinson&#x2019;s Current Therapy in Equine Medicine</source>. <edition>7th</edition> ed (<year>2015</year>). <fpage>465</fpage>&#x2013;<lpage>9</lpage>.</citation>
</ref>
<ref id="ref20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>RY</given-names></name> <name><surname>Chang</surname> <given-names>H</given-names></name></person-group>. <article-title>Renal dysplasia</article-title>. <source>Arch Pathol Lab Med</source>. (<year>2015</year>) <volume>139</volume>:<fpage>547</fpage>&#x2013;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.5858/ARPA.2013-0660-RS</pub-id></citation>
</ref>
<ref id="ref21">
<label>21.</label>
<citation citation-type="other"><person-group person-group-type="author"><name><surname>Engen</surname> <given-names>RM</given-names></name> <name><surname>Hingorani</surname> <given-names>S</given-names></name></person-group>. <article-title>Developmental abnormalities of the kidneys</article-title> In: <source>Avery&#x2019;s Diseases of the Newborn</source> (<year>2024</year>). <fpage>1100</fpage>&#x2013;<lpage>1110.e4</lpage>.</citation>
</ref>
<ref id="ref22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eid</surname> <given-names>S</given-names></name> <name><surname>Iwanaga</surname> <given-names>J</given-names></name> <name><surname>Loukas</surname> <given-names>M</given-names></name> <name><surname>Oskouian</surname> <given-names>RJ</given-names></name> <name><surname>Tubbs</surname> <given-names>RS</given-names></name></person-group>. <article-title>Pelvic kidney: a review of the literature</article-title>. <source>Cureus</source>. (<year>2018</year>) <volume>10</volume>:<fpage>e2775</fpage>. doi: <pub-id pub-id-type="doi">10.7759/CUREUS.2775</pub-id>, PMID: <pub-id pub-id-type="pmid">30109168</pub-id></citation>
</ref>
<ref id="ref23">
<label>23.</label>
<citation citation-type="other"><person-group person-group-type="author"><name><surname>Yap</surname> <given-names>WW</given-names></name> <name><surname>Wah</surname> <given-names>T</given-names></name> <name><surname>Joyce</surname> <given-names>AD</given-names></name></person-group>. <article-title>Horseshoe kidney</article-title> In: <source>Smith&#x2019;s Textbook of Endourology</source>, vol. <volume>1</volume>. <edition>3rd</edition> ed (<year>2022</year>). <fpage>702</fpage>&#x2013;<lpage>6</lpage>.</citation>
</ref>
<ref id="ref24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duong</surname> <given-names>HP</given-names></name> <name><surname>Piepsz</surname> <given-names>A</given-names></name> <name><surname>Collier</surname> <given-names>F</given-names></name> <name><surname>Khelif</surname> <given-names>K</given-names></name> <name><surname>Christophe</surname> <given-names>C</given-names></name> <name><surname>Cassart</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Predicting the clinical outcome of Antenatally detected unilateral Pelviureteric junction stenosis</article-title>. <source>Urology</source>. (<year>2013</year>) <volume>82</volume>:<fpage>691</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1016/J.UROLOGY.2013.03.041</pub-id>, PMID: <pub-id pub-id-type="pmid">23726167</pub-id></citation>
</ref>
<ref id="ref25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vivante</surname> <given-names>A</given-names></name> <name><surname>Kleppa</surname> <given-names>MJ</given-names></name> <name><surname>Schulz</surname> <given-names>J</given-names></name> <name><surname>Kohl</surname> <given-names>S</given-names></name> <name><surname>Sharma</surname> <given-names>A</given-names></name> <name><surname>Chen</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Mutations in TBX18 cause dominant urinary tract malformations via transcriptional dysregulation of ureter development</article-title>. <source>Am J Hum Genet</source>. (<year>2015</year>) <volume>97</volume>:<fpage>291</fpage>&#x2013;<lpage>301</lpage>. doi: <pub-id pub-id-type="doi">10.1016/J.AJHG.2015.07.001</pub-id>, PMID: <pub-id pub-id-type="pmid">26235987</pub-id></citation>
</ref>
<ref id="ref26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Merlini</surname> <given-names>E</given-names></name> <name><surname>Spina</surname> <given-names>P</given-names></name></person-group>. <article-title>Primary non-refluxing megaureters</article-title>. <source>J Pediatr Urol</source>. (<year>2005</year>) <volume>1</volume>:<fpage>409</fpage>&#x2013;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jpurol.2005.04.007</pub-id>, PMID: <pub-id pub-id-type="pmid">18947581</pub-id></citation>
</ref>
<ref id="ref27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dekirmendjian</surname> <given-names>A</given-names></name> <name><surname>Braga</surname> <given-names>LH</given-names></name></person-group>. <article-title>Primary non-refluxing megaureter: analysis of risk factors for spontaneous resolution and surgical intervention</article-title>. <source>Front Pediatr</source>. (<year>2019</year>) <volume>7</volume>:<fpage>126</fpage>. doi: <pub-id pub-id-type="doi">10.3389/FPED.2019.00126/BIBTEX</pub-id></citation>
</ref>
<ref id="ref28">
<label>28.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kozlov</surname> <given-names>VM</given-names></name> <name><surname>Schedl</surname> <given-names>A</given-names></name></person-group>. <article-title>Duplex kidney formation: developmental mechanisms and genetic predisposition</article-title>. <source>F1000Res</source>. (<year>2020</year>):<fpage>9</fpage>. doi: <pub-id pub-id-type="doi">10.12688/F1000RESEARCH.19826.1/DOI</pub-id></citation>
</ref>
<ref id="ref29">
<label>29.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arena</surname> <given-names>S</given-names></name> <name><surname>Iacona</surname> <given-names>R</given-names></name> <name><surname>Impellizzeri</surname> <given-names>P</given-names></name> <name><surname>Russo</surname> <given-names>T</given-names></name> <name><surname>Marseglia</surname> <given-names>L</given-names></name> <name><surname>Gitto</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Physiopathology of vesico-ureteral reflux</article-title>. <source>Ital J Pediatr</source>. (<year>2016</year>) <volume>42</volume>:<fpage>103</fpage>. doi: <pub-id pub-id-type="doi">10.1186/S13052-016-0316-X</pub-id>, PMID: <pub-id pub-id-type="pmid">27899160</pub-id></citation>
</ref>
<ref id="ref30">
<label>30.</label>
<citation citation-type="other"><person-group person-group-type="author"><name><surname>Banker</surname> <given-names>H</given-names></name> <name><surname>Aeddula</surname> <given-names>NR</given-names></name></person-group>. <source>Vesicoureteral reflux.</source> <publisher-name>StatPearls</publisher-name>. (<year>2022</year>). <comment>Available at:</comment> <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK563262/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/books/NBK563262/</ext-link> (Accessed September 25, 2022).</citation>
</ref>
<ref id="ref31">
<label>31.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Eerde</surname> <given-names>AM</given-names></name> <name><surname>Duran</surname> <given-names>K</given-names></name> <name><surname>van Riel</surname> <given-names>E</given-names></name> <name><surname>de Kovel</surname> <given-names>CG</given-names></name> <name><surname>Koeleman</surname> <given-names>BP</given-names></name> <name><surname>Knoers</surname> <given-names>NV</given-names></name> <etal/></person-group>. <article-title>Genes in the ureteric budding pathway: association study on vesico-ureteral reflux patients</article-title>. <source>PLoS One</source>. (<year>2012</year>) <volume>7</volume>:<fpage>e31327</fpage>. doi: <pub-id pub-id-type="doi">10.1371/JOURNAL.PONE.0031327</pub-id>, PMID: <pub-id pub-id-type="pmid">22558067</pub-id></citation>
</ref>
<ref id="ref32">
<label>32.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname> <given-names>S</given-names></name> <name><surname>Lotfollahzadeh</surname> <given-names>S</given-names></name></person-group>. <article-title>Bladder Exstrophy</article-title>. <source>Case Stud Pediatr Anesth</source>. (<year>2022</year>) <volume>3</volume>:<fpage>189</fpage>&#x2013;<lpage>92</lpage>. doi: <pub-id pub-id-type="doi">10.1017/9781108668736.045</pub-id></citation>
</ref>
<ref id="ref33">
<label>33.</label>
<citation citation-type="journal"><person-group person-group-type="author">
<name><surname>Khemchandani</surname> <given-names>S</given-names></name>
</person-group>. <article-title>Triad of bladder agenesis with solitary kidney and ectopic ureter</article-title>. <source>Indian J Urol</source>. (<year>2008</year>) <volume>24</volume>:<fpage>566</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.4103/0970-1591.44271</pub-id>, PMID: <pub-id pub-id-type="pmid">19468521</pub-id></citation>
</ref>
<ref id="ref34">
<label>34.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pacheco-Mendoza</surname> <given-names>BA</given-names></name> <name><surname>Gonz&#x00E1;lez-Led&#x00F3;n</surname> <given-names>FJ</given-names></name> <name><surname>D&#x00ED;az-Pardo</surname> <given-names>M</given-names></name> <name><surname>Soto-Blanquel</surname> <given-names>JL</given-names></name> <name><surname>Castel&#x00E1;n-Mart&#x00ED;nez</surname> <given-names>OD</given-names></name></person-group>. <article-title>Bladder agenesis and incomplete kidney duplication: Ileal reservoir with continent diversion as definitive treatment</article-title>. <source>Can Urol Assoc J</source>. (<year>2015</year>) <volume>9</volume>:<fpage>142</fpage>&#x2013;<lpage>E144</lpage>. doi: <pub-id pub-id-type="doi">10.5489/CUAJ.2534</pub-id>, PMID: <pub-id pub-id-type="pmid">25844102</pub-id></citation>
</ref>
<ref id="ref35">
<label>35.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lata</surname> <given-names>S</given-names></name> <name><surname>Marasa</surname> <given-names>M</given-names></name> <name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Fasel</surname> <given-names>DA</given-names></name> <name><surname>Groopman</surname> <given-names>E</given-names></name> <name><surname>Jobanputra</surname> <given-names>V</given-names></name> <etal/></person-group>. <article-title>Whole-exome sequencing in adults with chronic kidney disease: a pilot study</article-title>. <source>Ann Intern Med</source>. (<year>2018</year>) <volume>168</volume>:<fpage>100</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.7326/M17-1319</pub-id>, PMID: <pub-id pub-id-type="pmid">29204651</pub-id></citation>
</ref>
<ref id="ref36">
<label>36.</label>
<citation citation-type="other"><person-group person-group-type="author"><name><surname>Bingham</surname> <given-names>G</given-names></name> <name><surname>Rentea</surname> <given-names>RM</given-names></name></person-group>. <article-title>Posterior urethral valve</article-title> In: <source>Operative Pediatric Surgery</source>. <edition>7th</edition> ed (<year>2022</year>). <fpage>846</fpage>&#x2013;<lpage>61</lpage>.</citation>
</ref>
<ref id="ref37">
<label>37.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chesnaye</surname> <given-names>N</given-names></name> <name><surname>Bonthuis</surname> <given-names>M</given-names></name> <name><surname>Schaefer</surname> <given-names>F</given-names></name> <name><surname>Groothoff</surname> <given-names>JW</given-names></name> <name><surname>Verrina</surname> <given-names>E</given-names></name> <name><surname>Heaf</surname> <given-names>JG</given-names></name> <etal/></person-group>. <article-title>Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA-EDTA registry</article-title>. <source>Pediatr Nephrol</source>. (<year>2014</year>) <volume>29</volume>:<fpage>2403</fpage>&#x2013;<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.1007/S00467-014-2884-6</pub-id>, PMID: <pub-id pub-id-type="pmid">25039018</pub-id></citation>
</ref>
<ref id="ref38">
<label>38.</label>
<citation citation-type="journal"><person-group person-group-type="author">
<name><surname>Yosypiv</surname> <given-names>IV</given-names></name>
</person-group>. <article-title>Congenital anomalies of the kidney and urinary tract: a genetic disorder?</article-title> <source>Int J Nephrol</source>. (<year>2012</year>) <volume>2012</volume>:<fpage>909083</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2012/909083</pub-id>, PMID: <pub-id pub-id-type="pmid">22685656</pub-id></citation>
</ref>
</ref-list>
</back>
</article>